BioImpact Equities Fund, LP is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Mar 10, 2026, the fund has sold $125,453,844 of interests to 93 investors since its first sale in Jan 2011. The filing does not set a minimum investment. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Christiana Bardon; Kristen Laguerre; Christopher Wolf.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $125,453,844Cumulative sales reported on Form D
- Investors
- 93
- First sale
- Jan 1, 2011
- Minimum investment
- None set
- Who can invest
- Not stated
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Christiana Bardon; Kristen Laguerre; Christopher Wolf
- Latest Form D
- Mar 10, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about BioImpact Equities Fund, LP
What is the minimum investment for BioImpact Equities Fund, LP?
BioImpact Equities Fund, LP's latest Form D, filed Mar 10, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in BioImpact Equities Fund, LP?
BioImpact Equities Fund, LP is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(b), which does not allow general advertising.
How much has BioImpact Equities Fund, LP raised?
BioImpact Equities Fund, LP reports $125,453,844 sold from 93 investors on its Form D filed Mar 10, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is BioImpact Equities Fund, LP based?
BioImpact Equities Fund, LP is based in Boston, Massachusetts.
When did BioImpact Equities Fund, LP launch?
BioImpact Equities Fund, LP reports its first sale in Jan 2011.
Size compared with every hedge fund
Raised more than 51% of the 474 hedge funds based in Massachusetts, and more than 62% of all 10,308 that report sales.
Other funds with the same team
More hedge funds in Boston
Similar-size hedge funds in Massachusetts
- Acadian Global All-Country ex-U.S. ex-China Equity Dynamic Extension Fund$125M
- HighVista HFS Partners (Offshore) SPC - Portfolio A$133M
- VV Capital Partners, LP$125M
- Double Play Partners, L.P.$134M
- PanAgora Risk Managed Global Opportunities Fund (10V), LLC$125M
- Acadian Global Equity Absolute Return Fund, LLC$136M